Team Novo Nordisk Strengthens Bond with Novo Nordisk Until 2031
Team Novo Nordisk Partners with Novo Nordisk for Future Growth
The world's leading all-diabetes professional cycling team extends their collaboration with the global healthcare giant through 2031. This significant milestone was announced on World Diabetes Day, reflecting a deep mutual commitment.
Overview of the Extended Partnership
Building upon the existing agreement that spans from 2023 to 2026, the partnership is set to continue for an additional five years. This extension to 2031 marks the longest ongoing collaboration in the team's history, highlighting Novo Nordisk's dedication to creating meaningful change for people living with diabetes around the globe.
Transforming Diabetes Perceptions Through Sport
Since their partnership commenced in 2012, Team Novo Nordisk and Novo Nordisk have been at the forefront of altering public perceptions about diabetes. The foundation of their synergy is rooted in the powerful idea of bringing together athletes with type 1 diabetes, showcasing that living with diabetes does not limit one's potential for a lively and fulfilling life.
Empowering Athletes and Communities
This collaboration harnesses sports, science, and storytelling to inspire individuals to lead healthier lives while driving lasting improvements in healthcare outcomes. By participating in professional cycling, the team exemplifies that diabetes does not dictate one's abilities, pushing the boundaries of what is achievable.
Message from Leadership
“Team Novo Nordisk embodies the belief that people with diabetes can accomplish anything,” said Phil Southerland, CEO and Co-Founder. He emphasizes that over the past years, their relationship has ripened into a global movement challenging societal views about diabetes. The extended partnership aims to continue inspiring the diabetes community worldwide while showcasing excellence in elite cycling competitions.
Commitment to Health and Wellness
As part of the new phase of this partnership, Team Novo Nordisk will keep competing at high levels and managing their condition daily while expanding outreach and educational initiatives. Meanwhile, Novo Nordisk remains focused on its mission to innovate medicines to enhance care and improve quality of life for individuals with chronic ailments.
Impacting Future Generations
In celebration of World Diabetes Day 2025, Team Novo Nordisk will actively support the World Diabetes Foundation's project aimed at enhancing diabetes management for children in rural areas, specifically focusing on those with type 1 diabetes.
Contribution Towards Positive Change
To support this initiative, Team Novo Nordisk pledges to donate 10% of profits from their international webshop until the end of 2025. This contribution will ensure that children with diabetes in underserved areas can access the essential care they require.
The Power of Collaboration
Elin Jäger, Senior Vice President at Novo Nordisk, stated, “The partnership's extension underscores our commitment to actively impact the lives of those living with diabetes. By merging sports with education and community outreach, we aim to dismantle the stigma surrounding diabetes, fostering hope and promoting healthy lifestyles among children.”
A Legacy of Achievement
Team Novo Nordisk has participated in numerous global events, amassing an impressive track record that includes covering over 75,000 kilometers each season and securing podium finishes and youth classifications. Their first white jersey win at the Loire Tour showcases their considerable accomplishments.
Advocating for Diabetes Awareness
The athletes of Team Novo Nordisk serve as influential representatives of diabetes awareness, motivating others and illustrating that with proper support, individuals with diabetes can excel in their pursuits. The continuation of this partnership will deepen the connection between the team, its athletes, and the 70,000 hardworking employees of Novo Nordisk, all striving to enhance the lives of over 45 million customers worldwide.
Conclusion of a Dynamic Journey
Phil Southerland concluded, “Novo Nordisk's unwavering support has been key to our mission of inspiring and empowering those with diabetes. Together, we will continue to break barriers and drive meaningful change for long-term health.”
Frequently Asked Questions
What is the significance of the partnership between Team Novo Nordisk and Novo Nordisk?
This partnership emphasizes the commitment to transform perceptions of diabetes through sport and advocacy, inspiring individuals to take charge of their health.
How long is the partnership extension?
The partnership has been extended for five additional years, now lasting until 2031.
What initiatives will Team Novo Nordisk support?
Team Novo Nordisk will support the World Diabetes Foundation to improve the quality of life for children with type 1 diabetes, particularly in rural regions.
How can people support Team Novo Nordisk's mission?
You can support the team by purchasing items from their webshop, as 10% of profits will go towards diabetes initiatives.
Who are the key figures in this partnership?
Phil Southerland, CEO and Co-Founder of Team Novo Nordisk, and Elin Jäger, Senior Vice President at Novo Nordisk, are pivotal in this collaboration.
About The Author
Contact Lucas Young privately here. Or send an email with ATTN: Lucas Young as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.